Zhonglin Hao, Alberto Chiappori, Ben C. Creelan, Reinhold Munker, Paul Otto Schwarzenberger, Nitin Patel, Sahista Vahora, Christian Davis, Chuan Wang, Jinghui Zhang, Lijun Xin, Adam Jacob Schoenfeld, Jacob Sands. "Preliminary results from an ongoing phase 1 study of LB2102, a dnTGFBR2-armored DLL3-targeted autologous CAR-T cell therapy, in patients with relapsed or refractory SCLC or LCNEC.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8012